Clinical Practice Updates
Accreditation Update
Clinical Practice Guidelines
- AASLD Updated Guidelines for the Treatment of Hepatitis C (Oct. 2011)
- 2011 Focused Update: ACCF/AHA Guidelines for the Treatment of Atrial Fibrillation
- HIV Guideline Update
- IDSA Guidelines for the Treatment of MRSA Infection
Clinical Practice Tool
- Management of Dry Mouth in the Long Term Care Patient (Oct. 2011)
- Symbicort® Supportive Resources (Oct. 2011)
- Nestlé Care Initiative Newsletter (Oct. 2011)
- Guidelines for Drug Dosing in Chronic Kidney Disease
- Fall and Fracture Prevention Program Resource Kit
- Online Resources for Flu Planning
- Long Term Care Influenza Management Toolkit
- healthForward™: Achieving Glycemic Control-Blood Glucose Monitoring and A1C testing
- Fast Facts for Providers-Clinical Practice: Summary for Diabetes Management in the Long Term Care Setting
- Sliding Scale Insulin: Reading Between the Lines
- Medication Financial Assistance Programs
Clinical Study Summary
- Safety and Efficacy of Sitagliptin Monotherapy Studied in the Elderly
- Comparative Effectiveness Study of Outcomes of Tiotropium Containing Regimens in COPD
Disease State Education
Drug Interaction Update
JCAHO Update
Journal Article Reviews
- G-Tube Administration of Creon® (Sept. 2011)
- New Algorithm for the Treatment of Type II Diabetes
- Managing the Risks of Triple Antithrombotic Therapy
New Drug Approvals
- FDA Approves Soliris, Combivent Respimat, Juvisync, Ferriprox and Onfi. (Oct. 2011)
- FDA Approves Nucynta® ER, Xalkori® and Firazyr® (Sept. 2011)
Pharmacy Practice Tools
- Celiac Disease and Gluten Content in Medication Resources for Pharmacists (Sept. 2011)
- Institute of Safe Medication Practices “List of Confused Drug Names” (Sept. 2011)
Pharmacy Practice Update
- FDA Posts Instructions for Disposal of Select Medications
- FDA Statement on Stockpiled Antivirals Nearing Expiration
Pipeline Update
- Treatment of C. Difficile Infection: Fidaxomicin Non-Inferior to Vancomycin
- Overview of Hep. C Treatments – Current and Future